The TNF-α mediated signaling pathway has been extensively studied and several inhibitors or monoclonal-antibodies have been successfully used for the treatment of rheumatoid arthritis and inflammatory bowel disease [41, 42]. Here, TNF is linked to rheumatoid arthritis.